insights_auto
Why is TMCI up 2,05%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,48 $
arrow_upward
+2,05%(+0,090) 1D
5 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
210,72 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
210,72 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
The Information
·
14 րոպե առաջ
DayOne Data Centers Files for Nasdaq IPO amid Market Uncertainty
TheStreet Pro
·
15 րոպե առաջ
Stocks Shrug Off New Highs in Yields as the Advance Broadens
24/7 Wall St.
·
28 րոպե առաջ
3 ETFs Measured From the Same 2005 Starting Line. The Plain S&P 500 Fund Turned $10,000 Into $92,435
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc